Aino Health AB (Publisher)
This English document is a translation of the Swedish original. In case of any discrepancy, the Swedish original shall prevail.
Extend your existing contract. Improved cash flow.
January to March 2024
• Net sales were KSEK 5,994 (6,180).
• Profit or loss after financial items was KSEK -2,943 (-2,791).
• Earnings per share were -0,0 SEK (-0,1).
Recently, our customer network continues to grow. We are pleased to announce that several of our existing customers have chosen to extend their licenses to include even more employees. This is not only a testament to the success of our platform, but also to the growing focus on employee sustainability among companies and organizations. Our customers recognize that a healthy and sustainable working environment is key to long-term success and growth. Investing in the well-being and health of your employees not only increases your company's productivity and profitability, but also strengthens the bond between your employees and the organization as a whole.
A key factor behind this success is technological advancement. We are investing heavily in improving our platform so we can create even more value from our customers' data. Through advanced analytics and customized solutions, we can now provide our clients with deep insights that help them foster a culture of well-being and sustainability in the workplace.
At Aino Health, we are committed to being our clients' trusted partner in promoting workforce sustainability. We believe that a healthy and thriving workforce is the foundation of an organization's success, and we're proud to support our customers' efforts toward this goal.
Current business funds
At the time of publication of the first quarter interim report, a rights issue is planned with a subscription period of June 2024, but the outcome is still unknown. The Board of Directors believes that the results of the planned issues and the achievement of the sales forecasts are favorable to creating conditions for business continuity into the 2024 financial year. Management acknowledges, but takes into account, the uncertainties associated with these assumptions. Risks should be manageable and we are continually working to overcome them.
The information contained herein is made publicly available by Aino Health AB (Publisher) in accordance with the EU Market Abuse Regulation. This information was published on May 14, 2024 at 8:30 am (Central European Time) through the agency of his CEO and President of Aino Health AB, Jyrki Eklund.
For more information
Jirki Eklund
Aino Health Representative Director
Phone: +358 40 042 4221
jyrki.eklund@ainohealth.com
story continues
Aino Health AB (publ) is listed on the Nasdaq Stockholm First North Growth Market (ticker: AINO).
certified advisor
Carnegie Investment Bank AB (Public)
For more information, please visit https://investors.ainohealth.com/certified-adviser/.
About Aino Health (public)
Aino Health is a leading provider of software-as-a-service solutions in corporate health management.
The company's complete system of SaaS platforms and services makes health, well-being, and safety an integral part of daily operations, helping businesses reduce sick leave, lower related costs, and increase productivity and employee engagement. improve outcomes. For more information, please visit ainohealth.com.
attachment
